Completed OBSERVATIONAL NCT01262534

A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.

Observational Epidemiological Registry to Assess the Clinical Profile in Patients With Moderate to Severe Psoriasis in Spain

Sponsor: Janssen-Cilag, S.A.

Conditions Psoriasis

Interventions Clinical profile of patients Patient Preferences about treatment Quality of Life

Updated 6 times since 2017 Last updated: May 3, 2013 Started: Oct 31, 2010 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01262534, this observational or N/A phase trial focuses on Psoriasis and remains completed. Sponsored by Janssen-Cilag, S.A., it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Janssen-Cilag, S.A.

Data source: Janssen-Cilag, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.